developed a method for the direct quantification of fusion events by flow cytometry, involving the staining of fusion partners with lipophilic probes and the use of fluorescence resonance energy transfer (FRET) to distinguish between fused and aggregated cells [7, 8] . Its application indicates that the time of reaction and initial proportion of fusion partners determine the number, relative size, and average cellular composition of syncytia. This quantitative approach, fully explained in the present article, has also shown that the heterogeneity of syncytia generated by envelope proteins-mediated cell-cell fusion may result in a variety of possible outcomes that, in turn, may influence the biological properties of the syncytia and surrounding cells, as well as viral replication.
While the previously mentioned articles in this special issue deal mainly with the entry of the viral content onto a target cell [1, 2, 6] , the article by José L. Neira [9] is focused on one of the key players of the HIV assembly process -the capsid protein. The ordered oligomerization of several hundred copies of this protein constitutes the scaffold for the new virion formation, enclosing the viral RNA and other proteins. The article fully reviews the role of the C-terminal domain of the capsid protein, CAC, as the driving force for viral assembly, its biophysical studies, its interaction with other proteins or lipids, and the promising development of drugs able to hamper capsid protein assembly, dimerization, or proper folding. Taken together, the results described suggest that the multiple roles of the HIV-capsid protein during viral assembly may be mediated by its rather unique ability to adopt different conformations, while preserving a similar supramolecular organization in response to different molecular environments and/or the interaction with other biomolecules.
Finally, the article by Santos et al. [10] presents a combined effort from clinicians and researchers to elucidate the changes in several biophysical and biochemical parameters of the blood cells of HIVinfected patients. In a previous paper [11] , the authors showed that lymphocytes and erythrocytes of HIV-1-infected patients, before antiretroviral therapy, presented significant changes in intracellular calcium concentration ([Ca 2+ ] int ) and membrane fluidity. In the present study, the same parameters were evaluated after efficient response to highly active antiretroviral therapy (HAART). When compared with the control group, both untreated and treated patients presented increased lymphocyte [Ca 2+ ] int and decreased lymphocyte membrane fluidity, without significant differences between the two groups of patients. On the contrary, the therapy reversed the membrane fluidity variations observed on erythrocytes. The decreased erythrocyte [Ca 2+ ] int of untreated patients was not reversed by HAART. As shown, AIDS patients present changes in lymphocyte (mostly noninfected) and erythrocyte properties, partially reversed by HAART, consistent with a process of facilitated propagation of the infection to new cells (viral fusion), stimulation of virion assembly, and maintenance of a reservoir of erythrocyte-bound infectious virus. These observations can be related with the action of the HIV Nef protein on the cell's proteins and lipid composition, as well as with the recently observed cell infection by HIV-1 via endocytosis.
This last study was conducted primarily on cells that were not infected by HIV -erythrocytes and a great majority of the total lymphocyte population of HIV-infected patients. This is probably one of its main goals and innovations, as well as one of the most relevant aspects of its results. Usually, most of the studies focused exclusively on HIV-infected cells. This makes the average lymphocyte population of HIV-infected patients and, specially, their erythrocytes quite overlooked systems. Most of the lymphocytes of a HIV-infected patient and all the erythrocytes are not infected by the virus, but, as these are the majority of the cells in circulation in HIV-infected patients and considering also the multitude of effects of the infection in organs and tissues in which cells are not infected, those cells should not be ignored. Furthermore, it is important to bear in mind that HIV can be found not only in infected cells and free in the blood plasma, but also bound to other cells, including "noninfectable" lymphocytes [12, 13] and erythrocytes [14, 15] , eventually constituting a reservoir of active virus in circulation.
